Stephen W. Scherer, PhD, FRSC
Senior Scientist
Director, The Centre for Applied Genomics, The Hospital for Sick Children
Phone: 416-813-1574

Stephen Scherer, PhD and FRSC, is a Senior Scientist at The Hospital for Sick Children in Genetics and Genomic Biology as well as Director of The Centre for Applied Genomics (TCAG). He is Associate Chief of the Research Institute at SickKids and Professor of Molecular Genetics at the University of Toronto. His research includes understanding the composition of the human genome for studies of genetic disease. Recent work characterizes structural and copy number variation in the human genome, and examines the role genetics has in autism spectrum disorder. Long standing endeavors include the study of human chromosome 7 as a model of the chromosomal basis of disease, and building genomics infrastructure to facilitate biomedical research. Over 250 peer-reviewed papers document this work (cited >14,000 times). Dr. Scherer has numerous honors such as the prestigious Steacie Prize in the Natural Sciences (2004), Fellow of the Royal Society of Canada (2007) and the Premier's Summit Award for Biomedical Research (2008). He is on the Scientific Advisory Board of Autism Speaks and Combimatrix Diagnostics, the Board of Trustees of Genome Canada and the Human Genome Organization and is a Scholar of the Canadian Institute for Advanced Research. Professor Scherer holds the GlaxoSmithKline-Canadian Institutes of Health Research Chair in Genetics and Genomics at the Hospital for Sick Children and University of Toronto.

Dr. Scherer will provide scientific expertise for the project and core services through The Centre for Applied Genomics (TCAG; for DNA isolation, genome-wide scanning, and high throughput sequencing. TCAG is a core facility within SickKids, and is a Science and Technology Platform for Genome Canada. Their mandate includes provision of research infrastructure and resources for investigators worldwide. Additionally, TCAG provides consultative resources related to genomics project design. TCAG is supported through major infrastructure funding from the Canada Foundation for Innovation (CFI), Genome Canada, the Ontario Government, the McLaughlin Centre for Molecular Medicine at the University of Toronto, and the SickKids Foundation.

Home  |   Who We Are  |   Our Purpose  |   Researchers  |   Publications  |   Affiliations